FDA Warning Letters 94% In Concurrence With Chief Counsel At Six Months

FDA warning and "untitled" letters are in sync with the Office of the Chief Counsel's interpretations a significant majority of the time, based on a six-month review of the policy that shifted warning letter authority from the field to the legal office